Skip to main content
Eli LillyInvestment

Richter Partners with U.S. Pharma Giant to Advance Women’s Health

Source: Autobound Signal API · 114 signals tracked for Eli Lilly · updated

Get Eli Lilly's live signals in Claude or ChatGPT, or by API

AskWhat changed at Eli Lilly this week? Use Autobound signals for lilly.com.

What happened

Eli Lilly will acquire 381,354 Gedeon Richter ordinary shares for approximately USD 15 million as part of their licensing agreement.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

All Crime People Health Environment Eli Lilly and Company gedeon richter marketing authorization Pharmaceutical company pharmaceutical industry women's health Richter Partners with U.S. Pharma Giant to Advance Women's Health Hungary Today 2026.11.13. Print without picture Print with picture Gedeon Richter has entered into a licensing agreement with Eli Lilly and Company to develop new therapies. Under the terms of the agreement, Richter will grant Lilly exclusive worldwide rights to develop, manufacture and commercialize the jointly developed medicines for the treatment of women's health conditions and cardiometabolic diseases. Under a separate supply agreement, Richter would supply Lilly with the active pharmaceutical ingredient Estetrol (E4) and, should Lilly exercise its co-commercialization option, the estrogen monotherapy product as well. Upon closing of the transaction, Lilly will make an upfront cash payment to Richter and acquire ordinary shares in the Hungarian pharmaceutical company. In addition, Richter will be eligible for regulatory and commercial milestone payments, as well as tiered royalties on net sales of the combination products. Lilly will acquire 381,354 Richter ordinary shares currently held in treasury, for a total consideration of approximately USD 15 million. Richter has also granted Lilly an option to co-commercialize its orally administered...

Keep reading with a free account

The rest of this article, and every signal for Eli Lilly, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Investment

What this signalsAn investment often shows where the company plans to grow.

Amount named
$15M
Financing type
Equity

Companies

  • Gedeon RichterRelated companygedeonrichter.com

More investment signals at other companies

The full record

From the Signal API record

Numbers

Amount named in the story
$15M

Extraction

Confidence
90%
Detected
Nov 13, 2026
signal_type
news
signal_subtype
invests_into

Use this data

Get every investment signal for Eli Lilly and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Eli Lilly this week?”

  2. Send it to your own tools

    The Signal API returns investment signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/23538afb-daaa-110b-3872-8f7086aa66a8 returns this record as JSON. POST /v1/companies/enrich returns every signal for lilly.com.

{
  "signal_id": "23538afb-daaa-110b-3872-8f7086aa66a8",
  "signal_type": "news",
  "signal_subtype": "invests_into",
  "detected_at": "2026-11-13T08:12:04+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "url": "https://hungarytoday.hu/richter-partners-with-u-s-pharma-giant-to-advance-womens-health/",
    "title": "Richter Partners with U.S. Pharma Giant to Advance Women’s Health - Hungary Today",
    "excerpt": "All Crime People Health Environment Eli Lilly and Company gedeon richter marketing authorization Pharmaceutical company pharmaceutical industry women's health Richter Partners with U.S. Pharma Giant to Advance Women’s Health Hungary Today 2026.11.13. Print without picture Print with picture Gedeon Richter has entered into a licensing agreement with Eli Lilly and Company to develop new therapies. Under the terms of the agreement, Richter will grant Lilly exclusive worldwide rights to develop, manufacture and commercialize the jointly developed medicines for the treatment of women’s health conditions and cardiometabolic diseases. Under a separate supply agreement, Richter would supply Lilly with the active pharmaceutical ingredient Estetrol (E4) and, should Lilly exercise its co-commercialization option, the estrogen monotherapy product as well. Upon closing of the transaction, Lilly will make an upfront cash payment to Richter and acquire ordinary shares in the Hungarian pharmaceutical company. In addition, Richter will be eligible for regulatory and commercial milestone payments, as well as tiered royalties on net sales of the combination products. Lilly will acquire 381,354 Richter ordinary shares currently held in treasury, for a total consideration of approximately USD 15 million. Richter has also granted Lilly an option to co-commercialize its orally administered, E4-based...",
    "summary": "Eli Lilly will acquire 381,354 Gedeon Richter ordinary shares for approximately USD 15 million as part of their licensing agreement.",
    "planning": true,
    "image_url": "https://hungarytoday.hu/wp-content/uploads/2024/06/20240613_094121.jpg",
    "confidence": 0.9,
    "published_at": "2026-11-13T08:12:04Z",
    "article_sentence": "Lilly will acquire 381,354 Richter ordinary shares currently held in treasury, for a total consideration of approximately USD 15 million.",
    "amount_normalized": 15000000,
    "financing_type_tags": [
      "equity"
    ],
    "related_company_name": "Gedeon Richter",
    "related_company_domain": "gedeonrichter.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.